Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2310677121Source: DataRank Database

Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 6.04)OA: hybridTopics (30)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Ting-Hui Lin ORCID,Chang‐Chun D. Lee ORCID,Akihiro Takamura ORCID,Rameshwar U. Kadam ORCID,Ding Zhang ORCID

Live enrichment

PubMed:38753503 OpenAlex:https://openalex.org/W4396950655

HHS | NIH | National Institute of General Medical Sciences

Grant: R35GM136286

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R01AI150885

HHS | NIH | National Institute of General Medical Sciences

Grant: K99GM138758

FWCI

6.04

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://www.pnas.org/doi/pdf/10.1073/pnas.2310677121

publisherhttps://www.pnas.org/doi/pdf/10.1073/pnas.2310677121

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2310677121

journalhttps://doi.org/10.1073/pnas.2310677121

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38753503

Fields of Study

Influenza Virus Research StudiesRespiratory viral infections researchRNA and protein synthesis mechanisms

MeSH Terms

AnimalsAntiviral AgentsChemistry, PharmaceuticalDogsHumansInfluenza, HumanInfluenza A virusCrystallography, X-RayHemagglutinin Glycoproteins, Influenza VirusHigh-Throughput Screening AssaysClick ChemistryMadin Darby Canine Kidney CellsViral Fusion Protein Inhibitors

Keywords

Lead compoundHemagglutinin (influenza)ChemistryDrug discoverySmall moleculeDrugClick chemistryComputational biologyCombinatorial chemistryBiologyBiochemistryPharmacologyGeneIn vitro

Sustainable Development Goals

SDG 0: Good health and well-being